1-3 of 3
Jaime A. Espinoza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4526: Inhibition of RNA Pol I transcription and induction of nucleolar stress in cancer cells treated with the experimental alpha-adrenergic receptor antagonist JP-1302

Free
Sheetanshu Saproo, Styliani Papadaki, Jaime A. Espinoza, Jiri Bartek, Mikael S. Lindström
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4526.
https://doi.org/10.1158/1538-7445.AM2024-4526
Published: 22 March 2024
View articletitled, Abstract 4526: Inhibition of RNA Pol I transcription and induction of nucleolar stress in cancer cells treated with the experimental alpha-adrenergic receptor antagonist JP-1302
Journal Articles

Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype

Free
Kaveh M. Goudarzi, Jaime A. Espinoza, Min Guo, Jiri Bartek, Monica Nistér, Mikael S. Lindström, Daniel Hägerstrand
Journal: Cancer Research
Series: Author Choice
Cancer Res (2018) 78 (20): 5901–5916.
https://doi.org/10.1158/0008-5472.CAN-18-0320
Published: 15 October 2018
View articletitled, Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Open the PDF for Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype in another window
Includes: Supplementary data
Journal Articles

Abstract 2274: Deregulated Hippo pathway is a potential therapeutic target for advanced gallbladder cancer

Free
Carolina Bizama, Patricia García, Jaime A Espinoza, Nicole Elgueta, Ismael Riquelme, Francisca Alfaro, Diego Romero, Helga Weber, Pamela Leal, Javier Retamal, Lorena Rosa, Juan Carlos Roa
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2274.
https://doi.org/10.1158/1538-7445.AM2016-2274
Published: 15 July 2016
View articletitled, Abstract 2274: Deregulated Hippo pathway is a potential therapeutic target for advanced gallbladder cancer